[1] [2] According to the FDA Prescribing Information, dizziness is not listed among the common adverse effects of Zepbound
When patients use syringes, units, and variable concentrations, dosing errors become easier
The results of the trial will inform future regulatory submissions for GTT@home use in type 1 diabetes, which already has regulatory approval in the UK, Europe and other regions for other types of diabetes
If pharmacies arent flagging this, were missing a crucial clinical cue, and a chance to intervene early
Can I take this supplement if I am on other medications
PubMed laboratory research record [PMID: 38496002] PubMed record related to this compound for laboratory literature review